Consider a speculative investment in Glasshouse Brands (GLASF), a profitable, low-cost California cannabis producer. The company has a significant cost advantage and the potential to more than double revenue to ~$500 million by utilizing its existing, unused greenhouse capacity. The primary catalyst for the stock is the potential federal rescheduling of cannabis from Schedule I to Schedule III, which would eliminate the punitive 280E tax and unlock significant profitability. This regulatory change could also open the door for interstate commerce, allowing GLASF to sell its low-cost product into higher-priced markets across the U.S. While a recent operational disruption will negatively impact near-term results, management expects a full revenue ramp by Q2 of next year.

Glasshouse Brands (GLASF)

• Glasshouse Brands is a vertically integrated cannabis company focused exclusively on the California market. The podcast host, Steve Eisman, disclosed that he is a recent shareholder and views the investment as "fairly speculative."
• The company is described as the largest cannabis cultivator on the planet, with 6 million square feet of greenhouse space.
• Unlike many competitors in the cannabis space, Glasshouse Brands is profitable and cash-flow positive.
  • In Q2, they reported a 53% gross margin and an approximate 18% EBITDA margin.
• Their primary business is the wholesale of cannabis biomass, but they also operate 11 retail stores and a manufacturing facility for products like gummies.
• Key Brands:
  • Glasshouse Farms: The company's flagship brand.
  • Allswell: A value-focused brand designed to compete directly with the illicit market. It is reportedly the most consumed cannabis flower in California, priced at $7.50 an eighth.
  • Plus: The company's main edibles brand.
• Cost Advantage: The company has a significant cost advantage, achieved through scale, automation, and growing in the ideal climate of Southern California.
  • They have driven their cost of production down by 50% in six quarters, from $182 per pound to $91 per pound.
  • Management estimates their production costs are 4 to 6 times lower than competitors, especially those operating in other states.
• Growth Potential: The company is currently operating at a fraction of its total capacity.
  • They are using 2 of their 5 productive greenhouses. Management suggests that at full capacity, annual revenue could grow from ~$200 million to ~$500 million based on current California prices alone.
• Risks & Setbacks Mentioned:
  • ICE Raid: In July, a major raid by Immigration and Customs Enforcement (ICE) disrupted operations and their labor force. This will negatively impact Q3 revenue.
    • Mitigation: The company has since implemented what they call a "bulletproof" worker verification system, hand-verifying all employee documentation with legal experts.
    • Timeline: They expect to be back to "normal production" in Q1 of next year, with a full revenue ramp by Q2.
  • Tax Position (280E): The company has taken the position that the IRS tax code 280E (which prohibits standard business deductions for companies trafficking in controlled substances) does not apply to them. If the IRS challenges this and wins, it could result in a marginal tax rate of 75-80%.

Takeaways

• Glasshouse Brands can be viewed as a play on low-cost, large-scale cannabis production. Their ability to operate profitably in California's hyper-competitive, low-price market is a key differentiator.
• The investment thesis is heavily tied to future regulatory changes. If cannabis is rescheduled or descheduled, allowing for interstate commerce, Glasshouse could see significant revenue and margin expansion by selling its low-cost product into higher-priced markets across the U.S. and internationally.
• The company has significant built-in growth capacity. Simply bringing their existing, unused greenhouses online could more than double their revenue, even without any changes to federal law.
• Investors should be aware of the speculative nature of the investment and the specific risks mentioned, including the recent operational disruption from the ICE raid and the potential for a future tax dispute with the IRS.

Cannabis Sector & Regulatory Change

• The cannabis industry is at a potential inflection point after being "left for dead" following the 2018 hype cycle. The host's interest was piqued by recent positive comments about cannabis from former President Trump.
• Current Regulatory Status:
  • Cannabis is classified as a Schedule I drug by the DEA, the most restrictive category, alongside drugs like heroin.
  • This status prohibits interstate commerce, restricts access to traditional banking and credit card processing, and prevents U.S. cannabis companies from listing on major exchanges like the NASDAQ or NYSE.
  • It also subjects companies to the punitive 280E tax code.
• Potential Catalysts for Change:
  • Rescheduling to Schedule III: This is the most widely discussed possibility. It would classify cannabis as a medicine with a lower potential for abuse.
    • Impact: This would likely eliminate the 280E tax burden. It is also believed it would open the door for uplisting to major exchanges and allow for credit card payments. The ability to ship products across state lines would still be a question mark, likely decided on a state-by-state basis.
  • Descheduling: This is a more aggressive but possible outcome. It would remove cannabis from the Controlled Substances Act entirely, treating it like alcohol and tobacco.
    • Impact: This would almost certainly legalize interstate and international commerce, allowing low-cost producers like Glasshouse Brands to compete nationwide and globally.
• Market Dynamics:
  • California's Dominance: California is considered the best place in the world to grow high-quality cannabis at a low cost. The theory is that companies profitable in California are best positioned to dominate a future national market.
  • Price Arbitrage: Prices for cannabis in other states (like New York or New Jersey) can be 2x to 4x higher than in California. In Europe, illicit California cannabis sells for 5x the price. Legal interstate commerce would unlock this massive price arbitrage for California producers.
  • Illicit Market: The illegal market still accounts for roughly two-thirds of all cannabis sales. Legal companies with low-cost structures are best positioned to compete with the illicit market on price while offering a tested, regulated, and safer product.

Takeaways

• An investment in a U.S. cannabis operator is largely a bet on federal regulatory reform. A move from Schedule I to Schedule III or a full deschedule would be a massive catalyst for the entire industry.
• The "California is king" thesis suggests that investors should look for companies that are already winning in the most competitive market. These companies have proven business models and low-cost structures that could allow them to thrive if and when national markets open up.
• The potential for interstate commerce is the single biggest opportunity. It would allow efficient producers to dramatically increase their revenue and profitability by selling into higher-priced markets, fundamentally changing the financial profile of companies like Glasshouse Brands.